• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lliac artery stenting shows good long-term results

Article

Endovascular stenting as the initial treatment for patients with occluded iliac arteries has been shown to be both safe and cost-effective by more than five years of follow-up in the Dutch Iliac Stent Trial.

Endovascular stenting as the initial treatment for patients with occluded iliac arteries has been shown to be both safe and cost-effective by more than five years of follow-up in the Dutch Iliac Stent Trial.

Dr. Willemijn M. Klein and colleagues retrospectively reviewed 143 patients who underwent primary stent placement and 136 who underwent primary angioplasty followed by selective stent placement. They found no statistically significant difference between the two groups in the number of reinterventions, additional cardiovascular events, or mortality.

The real danger for these patients is cardiovascular complications leading to fatal episodes, according to a study in the August issue of Radiology. Peripheral artery disease should thus be considered a marker of potentially dangerous atherosclerotic disease elsewhere in the body, the researchers said.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.